BHEL, Hyundai & more: Top stocks on brokers' radar today
Equirus downgraded Protean eGovernance due to losing a key government project, impacting revenue significantly. Jefferies maintains a hold on Divis Laboratories, citing patent challenges and valuation. Kotak has a sell rating on BHEL due to weak execution. CLSA is positive on Hyundai Motors India, while Morgan Stanley downgraded HAL due to concerns about execution guidance.
Equirus downgraded Protean eGovernance due to losing a key government project, impacting revenue significantly. Jefferies maintains a hold on Divis Laboratories, citing patent challenges and valuation. Kotak has a sell rating on BHEL due to weak execution. CLSA is positive on Hyundai Motors India, while Morgan Stanley downgraded HAL due to concerns about execution guidance.
